The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool

Previous prognostic models for second-line systemic therapy in patients with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving next-line targeted therapy after progression on first-line targeted therapy.02/12/2015
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news